Ittai Harel

Ittai is a Managing General Partner at Pitango Venture Capital, Israel’s largest Venture Capital fund with over $2 billion under management and investments in over 250 companies. He brings 15 years of management experience, and over ten years of experience in VC. His investment focus is on venture stage investments in Tech & Healthcare and includes Digital Health, Health-IT and MedTech. Before joining Pitango, Ittai headed up Corporate Development at Nektar Therapeutics (NASDAQ: NKTR) and served as Executive Vice President at IDGene Pharmaceuticals. He also served as Vice President of Business Development at IDEXX Laboratories (NASDAQ: IDXX). Ittai currently serves on the Board of Directors of LifeBond, EarlySense, Medisafe, Intensix, and Vertos Medical, and serves as Chairman of the Board at LifeBond and EarlySense. Ittai holds a B.Sc. in Chemical Engineering and Biotechnology from Ben-Gurion University, and an MBA from the MIT Sloan School of Management.